NATCO Pharma Launches Generic Blood Cancer Treatment Medicine In US
Natco Pharma has launched generic Pomalidomide capsules in the US in partnership with Breckenridge, targeting a $3.2 billion oncology market and securing 180 days of shared exclusivity.
Natco Pharma has launched generic Pomalidomide capsules in the US in partnership with Breckenridge, targeting a $3.2 billion oncology market and securing 180 days of shared exclusivity.
What's Your Reaction?
